• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产超广谱β-内酰胺酶大肠埃希菌作为社区获得性尿路感染病因的分子特征及药敏模式

[Molecular characterization and antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing Escherichia coli as cause of community acquired urinary tract infection].

作者信息

Galindo-Méndez Mario

机构信息

Laboratorios Galindo SC, Universidad Anáhuac Oaxaca, México.

出版信息

Rev Chilena Infectol. 2018;35(1):29-35. doi: 10.4067/s0716-10182018000100029.

DOI:10.4067/s0716-10182018000100029
PMID:29652969
Abstract

Background Community acquired urinary tract infections (CaUTI) caused by strains of extended-spectrum β-lactamases (ESBL) - producing Escherichia coli, mainly by strains carrying the blaCTX-M-15 gene, is a growing phenomenon worldwide. Aim To determine the antibiotic susceptibility pattern of ESBL-producing E. coli as cause of CaUTI and to identify their molecular pattern. Methods A descriptive study was performed in the city of Oaxaca, Mexico, from where 288 strains of CaUTI-producing strains of E. coli in adults with possible UTI were isolated. The CLSI criteria was followed to determine the antimicrobial susceptibility patterns, and their molecular characterization was performed by using PCR. Results 31.3% of E. coli strains isolated in our population were ESBL producers, which presented higher levels of antibiotic resistance than those of non-producers of these enzymes. 95.6% of the studied strains were carriers of the blaCTX-M gene. Conclusions One-third of the Ca-UTI caused by E. coli in our population are caused by ESBL-producing strains, which present high levels of resistance to the antibiotics widely used in our community. This situation considerably decreases the number of antibiotics available for an empiric treatment against these infections.

摘要

背景 由产超广谱β-内酰胺酶(ESBL)的大肠埃希菌菌株引起的社区获得性尿路感染(CaUTI),主要是携带blaCTX-M-15基因的菌株,在全球范围内呈增长趋势。目的 确定作为CaUTI病因的产ESBL大肠埃希菌的抗生素敏感性模式,并鉴定其分子模式。方法 在墨西哥瓦哈卡市进行了一项描述性研究,从可能患有尿路感染的成年人中分离出288株产CaUTI的大肠埃希菌菌株。遵循CLSI标准确定抗菌药物敏感性模式,并通过PCR进行分子特征分析。结果 在我们的研究人群中分离出的大肠埃希菌菌株中有31.3%是ESBL生产者,其抗生素耐药水平高于非这些酶生产者。95.6%的研究菌株携带blaCTX-M基因。结论 在我们的研究人群中,由大肠埃希菌引起的Ca-UTI中有三分之一是由产ESBL菌株引起的,这些菌株对我们社区广泛使用的抗生素呈现高水平耐药。这种情况大大减少了可用于针对这些感染进行经验性治疗的抗生素数量。

相似文献

1
[Molecular characterization and antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing Escherichia coli as cause of community acquired urinary tract infection].产超广谱β-内酰胺酶大肠埃希菌作为社区获得性尿路感染病因的分子特征及药敏模式
Rev Chilena Infectol. 2018;35(1):29-35. doi: 10.4067/s0716-10182018000100029.
2
Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.质粒介导产AmpCβ-内酰胺酶的大肠杆菌在奥克兰社区引起尿路感染,可能对常用抗菌药物耐药。
N Z Med J. 2015 Mar 13;128(1410):50-9.
3
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.携带超广谱β-内酰胺酶的大肠埃希菌引起社区获得性尿路感染的危险因素。
J Antimicrob Chemother. 2006 Apr;57(4):780-3. doi: 10.1093/jac/dkl035. Epub 2006 Feb 21.
4
Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.从住院和非住院患者中分离的大肠埃希菌产生的超广谱β-内酰胺酶的特性:导致尿路感染的 CTX-M-15 产菌株的出现。
Microb Drug Resist. 2010 Jun;16(2):129-34. doi: 10.1089/mdr.2009.0132.
5
Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.中国温州尿路感染中产超广谱β-内酰胺酶大肠埃希菌的药敏情况及耐药机制研究
Int J Antimicrob Agents. 2017 Jul;50(1):29-34. doi: 10.1016/j.ijantimicag.2017.02.010. Epub 2017 Apr 26.
6
Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia.突尼斯社区获得性尿路感染中产超广谱β-内酰胺酶大肠埃希菌的特征。
Microb Drug Resist. 2013 Jun;19(3):231-6. doi: 10.1089/mdr.2012.0172. Epub 2013 Jan 30.
7
CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.CTX-M 型超广谱β-内酰胺酶在土耳其欧洲部分一所大学获得的社区获得性上尿路感染大肠埃希菌分离株中的研究。
J Microbiol Immunol Infect. 2010 Apr;43(2):163-7. doi: 10.1016/S1684-1182(10)60026-6.
8
Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.医疗保健相关尿路感染中产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的抗菌药敏性:聚焦对磷霉素的敏感性
Int Urol Nephrol. 2015 Jul;47(7):1059-66. doi: 10.1007/s11255-015-1018-9. Epub 2015 May 31.
9
Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases of Escherichia coli and Klebsiella spp. Isolates from Urinary Tract Infections in Southern Brazil.巴西南部尿路感染分离出的大肠杆菌和克雷伯菌属超广谱β-内酰胺酶的耐药性及分子特征
Microb Drug Resist. 2019 Mar;25(2):173-181. doi: 10.1089/mdr.2018.0046. Epub 2018 Aug 22.
10
Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.印度阿里格尔J N M C医院社区获得性尿路感染的病因及抗生素耐药模式
Ann Clin Microbiol Antimicrob. 2007 Mar 23;6:4. doi: 10.1186/1476-0711-6-4.

引用本文的文献

1
Antimicrobial resistance profile and associated factors of hospital-acquired gram-negative bacterial pathogens among hospitalized patients in northeast Ethiopia.埃塞俄比亚东北部住院患者医院获得性革兰氏阴性细菌病原体的抗菌药物耐药谱及相关因素。
BMC Microbiol. 2024 Sep 11;24(1):339. doi: 10.1186/s12866-024-03485-0.
2
Uropathogenic and Hybrid Pathotypes in Mexican Women with Urinary Tract Infections: A Comprehensive Molecular and Phenotypic Overview.墨西哥女性尿路感染中的尿路致病性和杂交致病型:全面的分子和表型概述
Curr Issues Mol Biol. 2024 Jun 13;46(6):5909-5928. doi: 10.3390/cimb46060353.
3
Emergence of Fosfomycin Resistance by Plasmid-Mediated Genes in Uropathogenic ESBL-Producing Isolates in Mexico.
墨西哥产超广谱β-内酰胺酶的尿路致病性分离株中质粒介导基因导致磷霉素耐药性的出现。
Antibiotics (Basel). 2022 Oct 9;11(10):1383. doi: 10.3390/antibiotics11101383.
4
Phylogeny and antimicrobial resistance of extended-spectrum beta-lactamaseproducing Escherichia coli from hospitalized oncology patients in Perú.秘鲁住院肿瘤患者中产超广谱β-内酰胺酶的大肠埃希菌的系统发育和耐药性分析。
Biomedica. 2022 Sep 2;42(3):470-478. doi: 10.7705/biomedica.6263.
5
[Sensitivity pattern of E. coli at the National Medical Center of Bajío].[巴伊亚州国家医疗中心大肠杆菌的药敏模式]
Rev Med Inst Mex Seguro Soc. 2022 Aug 31;60(5):503-510.
6
High Prevalence of Extended-Spectrum Beta-Lactamases in Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study.中国成人严格定义的社区获得性尿路感染分离菌株中超广谱β-内酰胺酶的高流行率:一项多中心前瞻性临床微生物学和分子研究
Front Microbiol. 2021 Jul 7;12:663033. doi: 10.3389/fmicb.2021.663033. eCollection 2021.
7
Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.波兰南部肾病科住院患者病原体的微生物学与耐药性
Pol J Microbiol. 2018;67(4):517-524. doi: 10.21307/pjm-2018-061.